Silvia Bresolin
Overview
Explore the profile of Silvia Bresolin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
2333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andriano A, Desantis V, Marasco C, Marzollo A, Bresolin S, Resta N, et al.
Intern Emerg Med
. 2025 Jan;
PMID: 39873967
Inborn errors of immunity (IEI) entail a diverse group of disorders resulting from hereditary or de novo mutations in single genes, leading to immune dysregulation. This study explores the clinical...
2.
Gambarotto L, Russo L, Bresolin S, Persano L, DAmore R, Ronchi G, et al.
Adv Sci (Weinh)
. 2024 Dec;
12(5):e2308965.
PMID: 39680476
The core component of the class III phosphatidylinositol 3-kinase complex, Beclin 1, takes part in different protein networks, thus switching its role from inducing autophagy to regulating autophagosomal maturation and...
3.
Oikonomou A, Watrin T, Valsecchi L, Scharov K, Savino A, Schliehe-Diecks J, et al.
Heliyon
. 2024 Jul;
10(13):e34033.
PMID: 39071567
Combining multiple drugs broadens the window of therapeutic opportunities and is crucial for diseases that are currently lacking fully curative treatments. A powerful emerging tool for selecting effective drugs and...
4.
Rampazzo E, Persano L, Karim N, Hodgking G, Pinto R, Casciati A, et al.
Front Oncol
. 2024 Jun;
14:1307516.
PMID: 38884089
Introduction: Glioblastoma (grade IV) is the most aggressive primary brain tumor in adults, representing one of the biggest therapeutic challenges due to its highly aggressive nature. In this study, we...
5.
Marzollo A, Zampieri S, Barozzi S, Yousaf M, Quartararo J, De Rocco D, et al.
Br J Haematol
. 2024 May;
205(1):306-315.
PMID: 38815995
Thrombocytopenia 4 (THC4) is an autosomal-dominant thrombocytopenia caused by mutations in CYCS, the gene encoding cytochrome c (CYCS), a small haeme protein essential for electron transport in mitochondria and cell...
6.
Rossini L, Bonardi C, Bresolin S, Trevisson E, Marzollo A
J Clin Immunol
. 2024 Apr;
44(4):100.
PMID: 38625673
No abstract available.
7.
Casciati A, Taddei A, Rampazzo E, Persano L, Viola G, Cani A, et al.
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38396911
In the last few years, pulsed electric fields have emerged as promising clinical tools for tumor treatments. This study highlights the distinct impact of a specific pulsed electric field protocol,...
8.
Stocchero M, Corallo D, Bresolin S, Pantile M, Pirillo P, Bortolozzi R, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338881
The RNA-binding protein LIN28B, identified as an independent risk factor in high-risk neuroblastoma patients, is implicated in adverse treatment outcomes linked to metastasis and chemoresistance. Despite its clinical significance, the...
9.
Tretti Parenzan C, Molin A, Longo G, Gaffo E, Buratin A, Cani A, et al.
Blood Adv
. 2023 Nov;
8(5):1305-1319.
PMID: 38029383
Circular RNAs (circRNAs) are emerging molecular players in leukemogenesis and promising therapeutic targets. In KMT2A::AFF1 (MLL::AF4)-rearranged leukemia, an aggressive disease compared with other pediatric B-cell precursor (BCP) acute lymphoblastic leukemia...
10.
Mariotto E, Rampazzo E, Bortolozzi R, Rruga F, Zeni I, Manfreda L, et al.
Acta Neuropathol Commun
. 2023 Nov;
11(1):183.
PMID: 37978570
Chemotherapy resistance is considered one of the main causes of tumor relapse, still challenging researchers for the identification of the molecular mechanisms sustaining its emergence. Here, we setup and characterized...